Live Breaking News & Updates on Investment Banking Firm Canaccord Genuity

Depression Scores Did Not Differ Significantly Between Patients Who Used Psilocybin or Escitalopram at 6 weeks
These findings, from a phase 2, double-blind, randomized, controlled trial, were published in the New England Journal of Medicine. Patients (N=59) with long-standing, moderate to severe major depressive disorder were recruited via an advertisement in the United Kingdom in 2019. Patients were randomized to receive 2 doses of 25 mg psilocybin with a daily placebo for 6 weeks (n=30) or 2 doses of 1 mg psilocybin with 3 weeks of daily 10 mg escitalopram and 3 weeks of 20 mg escitalopram (n=29). Patients were assessed by magnetic resonance imaging (MRI) and performed cognitive and affective processing tasks. ....

United Kingdom , British Columbia , United States , Norfolk County , Richard Feynman , Irwin Simon , Tommy Chong , Matt Stang , Kareem Burke , Research Centre , A Company Witha Combined Market Cap , Toronto Stock Exchange , Acreage Holding Capital Partners , Investment Banking Firm Canaccord Genuity , Acreage Holdings , Health Canada , Cannabis Countdown , Legal Marijuana Industry , Number One Curated Weekly News , Psychedelics Industry News Stories , Yahoo Finance , Acquiring All , Acreage Holding Florida Operations , Acquired Certain Owned , Leased Real Estate Assets Used , Acreage Florida ,